Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Fumaric Acid Esters Do Not Reduce Inflammatory NF-κB/p65 Nuclear Translocation, ICAM-1 Expression and T-Cell Adhesiveness of Human Brain Microvascular Endothelial Cells.
Phase III study: Ocrelizumab significantly reduces disease activity in PPMS patients
Episode 60 with Dr. Timothy Vollmer on early, highly effective treatment
Suppression of CD4+ T cell activation by a novel inhibitor of Src family kinases.
Structure of the LINGO-1-anti-LINGO-1 Li81 antibody complex provides insights into the biology of LINGO-1 and the mechanism of action of the antibody therapy.
Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells.
Mycophenolate mofetil in multiple sclerosis: a multicentre retrospective study on 344 patients.
Episode 52 with Dr. David Tabby on migraines in MS
MS Patient, Ph.D.: Can We Separate Anxiety and Gender in MS?
A timing-of-birth effect on multiple sclerosis clinical phenotype.
An RNA profile identifies two subsets of multiple sclerosis patients differing in disease activity.
Biogen Idec and Genentech announce restructuring of anti-CD20 collaboration agreement
Safety Study of Combination Therapy with Intramuscular Avonex and Oral CellCept in Patients with Multiple Sclerosis
Comparative pharmacogenetics of multiple sclerosis: IFN-β versus glatiramer acetate.
Estriol preserves synaptic transmission in the hippocampus during autoimmune demyelinating disease.
Equivalent Gene Expression Profiles between Glatopa™ and Copaxone®.
Drug reprofiling using zebrafish identifies novel compounds with potential pro-myelination effects.
Microglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice.
Petite but Potent
Japanese macaque encephalomyelitis: a spontaneous multiple sclerosis-like disease in a nonhuman primate.
Mycophenolic acid inhibits IL-2-dependent T cell proliferation, but not IL-2-dependent survival and sensitization to apoptosis.
20th Annual Rehabilitation In Multiple Sclerosis (RIMS) Conference
Autoimmune tolerance eliminates relapses but fails to halt progression in a model of multiple sclerosis.
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.
Episode 48 with Dr. Bruce Cree on the EPIC, CLIMB, and SUMMIT clinical studies

Pages